Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ki.2010.442 | DOI Listing |
Publication Analysis
Top Keywords
pseudoporphyria associated
4
associated hemodialysis
4
pseudoporphyria
1
hemodialysis
1
Similar Publications
Drug-associated porphyria: a pharmacovigilance study.
Orphanet J Rare Dis
August 2024
Department of Pharmacy, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Article Synopsis
- * Researchers analyzed ADRs related to porphyria from January 2004 to March 2022 and narrowed down 406 drugs, ultimately identifying 52 drugs associated with adverse effects using various statistical algorithms.
- * The findings provide essential insights into the safety of drugs for porphyria carriers, helping healthcare providers make informed decisions and avoid prescribing harmful medications.
Drug-Induced Pseudoporphyria: A Case Report.
Cureus
April 2024
Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Article Synopsis
- - Pseudoporphyria is a rare skin condition that resembles porphyria cutanea tarda (PCT), and distinguishing between the two is crucial for accurate diagnosis.
- - It’s linked to chronic kidney failure, certain medications, and tanning bed use, and can cause skin issues like fragility, blisters, and scarring, especially in sun-exposed areas.
- - A case report highlights a 20-year-old male diagnosed with pseudoporphyria after ruling out true porphyria, who was treated with hydroxychloroquine sulfate and advised to take strict sun protection measures.
Dermatological Manifestations in Patients With Chronic Kidney Disease: A Review.
Cureus
January 2024
Digital Health, Universidad Nacional Autónoma de México, Ciudad de Mexico, MEX.
Article Synopsis
- Chronic kidney disease (CKD) progresses over time, leading to various skin-related symptoms as toxin levels and inflammation increase in the body.
- Nonspecific skin issues might include itching, dry skin, and pigmentation problems, while more specific conditions could involve serious disorders like eruptive xanthoma and nephrogenic systemic fibrosis.
- Recognizing these skin changes early is crucial for improving treatment outcomes and overall patient health, as they can indicate underlying CKD complications and the need for timely intervention.
Antineoplastic drugs-related medication-associated pseudoporphyria.
JAAD Case Rep
December 2023
Department of Dermatology, University of California, Davis Medical Center, Sacramento, California.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!